Cellectar Biosciences Inc
(CLRB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 35,704 | 40,345 | 46,778 | 53,627 | 57,165 |
| TOTAL | $36,572 | $41,393 | $47,125 | $54,402 | $57,940 |
| Non-Current Assets | |||||
| PPE Net | 345 | 254 | 287 | 318 | 356 |
| Other Non-Current Assets | 286 | 307 | 326 | 345 | 364 |
| TOTAL | $630 | $561 | $613 | $663 | $720 |
| Total Assets | $37,202 | $41,953 | $47,738 | $55,065 | $58,659 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 3,855 | 3,035 | 3,391 | 4,896 | 3,443 |
| TOTAL | $3,990 | $3,166 | $3,519 | $5,020 | $3,563 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 166 | 202 | 236 | 269 | 302 |
| TOTAL | $166 | $202 | $236 | $269 | $302 |
| Total Liabilities | $4,157 | $3,368 | $3,755 | $5,289 | $3,865 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 203 | 203 | 203 | 176 | 168 |
| Common Shares | 0 | 1 | 1 | 1 | 1 |
| Retained earnings | -150,898 | -144,980 | -139,161 | -133,133 | -126,775 |
| Other shareholders' equity | 1,382 | 1,382 | 8,638 | 11,747 | 18,888 |
| TOTAL | $33,045 | $38,585 | $43,983 | $49,776 | $54,795 |
| Total Liabilities And Equity | $37,202 | $41,953 | $47,738 | $55,065 | $58,659 |